Highland Capital Management LLC Has $3.89 Million Stock Holdings in Cigna Group $CI

Highland Capital Management LLC lessened its position in Cigna Group (NYSE:CI) by 20.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,478 shares of the health services provider’s stock after selling 3,551 shares during the period. Highland Capital Management LLC’s holdings in Cigna Group were worth $3,885,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in CI. Wilsey Asset Management Inc. lifted its position in Cigna Group by 2.9% in the 2nd quarter. Wilsey Asset Management Inc. now owns 101,936 shares of the health services provider’s stock valued at $33,698,000 after acquiring an additional 2,847 shares in the last quarter. SCS Capital Management LLC lifted its holdings in shares of Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after purchasing an additional 8,609 shares in the last quarter. Retirement Systems of Alabama boosted its position in shares of Cigna Group by 3.9% during the second quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after buying an additional 6,155 shares during the period. Modern Wealth Management LLC raised its position in Cigna Group by 91.3% in the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock valued at $1,030,000 after buying an additional 1,494 shares during the last quarter. Finally, Janney Montgomery Scott LLC lifted its stake in Cigna Group by 3.9% in the 2nd quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after acquiring an additional 1,357 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $274.86 on Friday. The company has a market cap of $73.42 billion, a price-to-earnings ratio of 12.12, a PEG ratio of 1.00 and a beta of 0.26. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a fifty day moving average price of $275.72 and a 200-day moving average price of $291.80.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter last year, the business earned $7.51 earnings per share. Cigna Group’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Insider Buying and Selling

In other news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Wells Fargo & Company lowered their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Leerink Partners reduced their price target on Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Wolfe Research lowered their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. Barclays cut their price objective on Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research report on Friday, October 31st. Finally, UBS Group set a $294.00 price target on Cigna Group in a research note on Wednesday, November 12th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $331.83.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.